Skip to Content
Merck
  • Mismatched perfusion defects secondary to recent methyl methacrylate embolization.

Mismatched perfusion defects secondary to recent methyl methacrylate embolization.

Clinical nuclear medicine (2012-12-18)
Garima Agrawal, Chadwick L Wright, Nicholas G Rhodes, Akash Sharma
ABSTRACT

Methyl methacrylate (MMA) pulmonary embolism is a serious potential complication of percutaneous vertebroplasty. We present a case of a 28-year-old man who presented to an outside institution with pleuritic chest pain after MMA vertebroplasty of the T11 thoracic vertebra for chronic back ache secondary to a previous traumatic fracture. Multifocal MMA pulmonary embolism was identified on CT. The patient was referred to our institution following a wedge resection for pulmonary infarction. V/Q scintigraphy was performed and demonstrated normal ventilation with multiple mismatched perfusion defects bilaterally. Patient subsequently underwent central and bilateral segmental pulmonary embolectomies.

MATERIALS
Product Number
Brand
Product Description

Supelco
Methyl methacrylate solution, certified reference material, 1000 μg/mL in methanol
Sigma-Aldrich
Methyl methacrylate, contains ≤30 ppm MEHQ as inhibitor, 99%
Sigma-Aldrich
Methyl methacrylate, 99%, stabilized